General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 981: BRAF gene mutation is seen in which of the following conditions?

A. Breast carcinoma
B. Melanoma (Correct Answer)
C. Osteosarcoma
D. Prostate carcinoma

Explanation: **Explanation:** The **BRAF gene** encodes a serine/threonine protein kinase that belongs to the RAF family. It is a critical component of the **MAPK/ERK signaling pathway**, which regulates cell growth, proliferation, and survival [1]. **Why Melanoma is Correct:** Mutations in the BRAF gene are the most common genetic alterations in cutaneous melanoma, occurring in approximately **40–60% of cases** [1], [3]. The most frequent mutation is a point mutation resulting in the substitution of valine for glutamic acid at codon 600 (**V600E**) [1]. This mutation leads to constitutive activation of the downstream signaling pathway, driving oncogenesis. This discovery has revolutionized treatment with the development of BRAF inhibitors like **Vemurafenib** and **Dabrafenib** [1]. **Why Other Options are Incorrect:** * **Breast Carcinoma:** Typically associated with mutations in **BRCA1/BRCA2**, **TP53**, or amplification of **HER2/neu** [2]. * **Osteosarcoma:** Characterized by complex karyotypes, most commonly involving mutations in tumor suppressor genes **RB1** (Retinoblastoma) and **TP53** (Li-Fraumeni syndrome). * **Prostate Carcinoma:** Frequently involves **PTEN** deletions, **TMPRSS2-ERG** gene fusions, and androgen receptor mutations. **High-Yield Clinical Pearls for NEET-PG:** * **Other BRAF-associated tumors:** Papillary Thyroid Carcinoma (most common mutation), Hairy Cell Leukemia (nearly 100% have V600E), and Langerhans Cell Histiocytosis (LCH). * **Colon Cancer:** BRAF mutations in colorectal cancer are associated with a poor prognosis and the serrated pathway of carcinogenesis. * **Zebrafenib/Vemurafenib:** These are the "magic bullets" for BRAF V600E positive metastatic melanoma. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1150-1151. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 292. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1152-1153.

Question 982: What is the most reliable investigation for amyloidosis?

A. Abdominal fat pad aspirate
B. Ultrasound (USG)
C. Urine examination
D. Kidney biopsy (Correct Answer)

Explanation: **Explanation:** The gold standard for the diagnosis of amyloidosis is the demonstration of amyloid deposits in tissue using **Congo red staining**, which shows characteristic **apple-green birefringence** under polarized light [1]. **Why Kidney Biopsy is the Correct Answer:** While amyloidosis is a systemic disease, the **kidney** is the most frequently involved organ and often the first to show clinical manifestations (like nephrotic syndrome) [1]. A kidney biopsy is considered the **most reliable investigation** because it has the highest diagnostic yield (nearly **90-100% sensitivity**) for detecting amyloid deposits compared to other sites. It allows for both confirmation of the diagnosis and assessment of the extent of renal damage. **Analysis of Incorrect Options:** * **Abdominal fat pad aspirate:** This is often the **initial screening test** of choice because it is simple, non-invasive, and safe. However, its sensitivity is lower (approx. 60-80%) than a direct organ biopsy. * **Ultrasound (USG):** USG is a supportive imaging modality. While it may show enlarged, echogenic kidneys in early stages, it cannot provide a definitive histopathological diagnosis. * **Urine examination:** This can detect complications like proteinuria (Bence-Jones proteins in Multiple Myeloma), but it cannot visualize amyloid fibrils [3]. **NEET-PG High-Yield Pearls:** * **Most common site for biopsy (Screening):** Abdominal fat pad or Rectal biopsy. * **Most common organ involved (Systemic Amyloidosis):** Kidney [2]. * **Stain of choice:** Congo Red (Apple-green birefringence) [1]. * **Electron Microscopy:** Shows non-branching fibrils (7.5 to 10 nm diameter) [1]. * **Secondary Amyloidosis (AA):** Most common cause in India is Tuberculosis; globally, it is Rheumatoid Arthritis [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-269. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136.

Question 983: Autoimmunity can be caused due to all of the following mechanisms except?

A. The pressure of forbidden clones
B. Expression of cryptic antigens
C. Negative selection of T-cells in the thymus (Correct Answer)
D. Inappropriate expression of MHC proteins

Explanation: ### **Explanation** The core concept behind autoimmunity is the **failure of self-tolerance**. To understand this question, one must distinguish between mechanisms that *prevent* autoimmunity and those that *cause* it. **Why "Negative selection of T-cells" is the correct answer:** Negative selection is a **protective mechanism**, not a cause of autoimmunity. It occurs in the thymus (central tolerance), where developing T-cells that react strongly to self-antigens are induced to undergo apoptosis [1]. This process ensures that self-reactive T-cells do not enter the peripheral circulation [1]. Therefore, negative selection **prevents** autoimmunity; its *failure* would cause it [3]. **Analysis of Incorrect Options (Causes of Autoimmunity):** * **A. Presence of forbidden clones:** According to Burnet’s Clonal Selection Theory, "forbidden clones" are self-reactive lymphocytes that should have been eliminated. If these clones survive and proliferate, they attack host tissues, leading to autoimmunity [3]. * **B. Expression of cryptic antigens:** Some self-antigens are "hidden" (sequestered) from the immune system (e.g., lens of the eye, sperm, CNS). If these are released due to trauma or inflammation, the immune system perceives them as foreign and mounts an attack. * **D. Inappropriate expression of MHC proteins:** Cells that do not normally express MHC Class II (like pancreatic beta cells) may do so under stress or viral infection [4]. This allows them to present self-antigens directly to T-helper cells, bypassing normal tolerance. ### **High-Yield Clinical Pearls for NEET-PG** * **Central Tolerance:** Occurs in the Thymus (T-cells) and Bone Marrow (B-cells) [1]. The primary mechanism is **Apoptosis (Negative Selection)** [1]. * **Peripheral Tolerance:** Occurs outside primary lymphoid organs. Key mechanisms include **Anergy** (functional inactivation via lack of co-stimulation) [2], **Suppression** by T-regs (CD4+, CD25+, FoxP3+) [2], and **Activation-Induced Cell Death (Fas-FasL pathway)** [1]. * **Molecular Mimicry:** A classic cause of autoimmunity where microbial antigens cross-react with self-antigens (e.g., Rheumatic Heart Disease) [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 220-221. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 176-177. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 228-230. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 224-226.

Question 984: Corpora amylacea are microscopic structures found in which of the following glands?

A. Parotid gland
B. Pineal gland
C. Prostate gland (Correct Answer)
D. Pituitary gland

Explanation: **Explanation:** **Corpora amylacea** (from Latin for "starch-like bodies") are small, laminated, hyaline masses found in the acini of the **prostate gland**. They are formed by the desquamation of epithelial cells and the inspissation (thickening) of prostatic secretions. 1. **Why Prostate Gland is Correct:** In the prostate, these bodies are composed of calcified glycoproteins [1]. They are a normal feature of the aging prostate and are frequently seen in cases of Benign Prostatic Hyperplasia (BPH) [2]. While they are typically microscopic, they can calcify further to form macroscopic "prostatic calculi." On H&E staining, they appear as eosinophilic, concentric rings [1]. 2. **Why Other Options are Incorrect:** * **Parotid Gland:** While salivary glands can develop sialoliths (stones), they do not typically form the classic laminated corpora amylacea seen in the prostate. * **Pineal Gland:** This gland is known for **Acervuli** (also called "brain sand" or *corpora arenacea*). These are larger calcifications used as radiological landmarks, distinct from the proteinaceous corpora amylacea. * **Pituitary Gland:** Does not characteristically feature these structures. **Clinical Pearls for NEET-PG:** * **Staining:** Despite the name "amylacea," they are not true starch; however, they may stain weakly positive with PAS (Periodic Acid-Schiff) due to their glycoprotein content. * **Other Locations:** Corpora amylacea are also found in the **brain** (specifically in the end-feet of astrocytes), where they increase with age and in neurodegenerative diseases. * **Differential:** Do not confuse *Corpora amylacea* (Prostate/CNS) with *Corpora arenacea* (Pineal gland) or *Psammoma bodies* (found in Papillary Thyroid Carcinoma, Meningioma, and Serous Ovarian Cystadenocarcinoma). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 496-497. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 986-988.

Question 985: Werner syndrome is characterized by which of the following?

A. Multiple Endocrine Neoplasia type I (MEN-I)
B. Multiple Endocrine Neoplasia type II (MEN-II)
C. Premature ageing (Correct Answer)
D. Defective sirtuins

Explanation: **Explanation:** **Werner Syndrome** is a rare autosomal recessive disorder characterized by **premature ageing** (progeria) [1]. It is caused by a mutation in the **WRN gene**, which encodes a member of the **RecQ helicase** family [1]. This enzyme is essential for DNA repair, replication, and maintaining telomere integrity. In its absence, cells accumulate genomic instability and enter replicative senescence prematurely, leading to the clinical manifestation of "adult progeria" [1]. **Analysis of Options:** * **A & B (MEN-I and MEN-II):** These are autosomal dominant syndromes involving endocrine tumors. While **Wermer Syndrome** (with an 'm') is another name for **MEN-I**, it is distinct from **Werner Syndrome** (with an 'n'). This is a common phonetic trap in exams. * **D (Defective sirtuins):** Sirtuins are NAD+-dependent deacetylases that promote longevity by inhibiting metabolic activity and increasing DNA repair. While decreased sirtuin activity is linked to the general aging process, it is not the primary molecular defect in Werner syndrome. **Clinical Pearls for NEET-PG:** * **Clinical Features:** Patients appear normal until puberty, followed by rapid aging: graying/loss of hair, bilateral cataracts, scleroderma-like skin changes, osteoporosis, and atherosclerosis. * **Malignancy Risk:** There is a significantly increased risk of rare cancers, particularly **soft tissue sarcomas** and osteosarcomas. * **Hutchinson-Gilford Progeria:** Unlike Werner (adult-onset), this is a childhood-onset progeria caused by mutations in the **LMNA gene** (Lamin A). * **Key Distinction:** Remember **Wermer** = MEN-1 (3 Ps: Pituitary, Parathyroid, Pancreas); **Werner** = WRN gene (Premature Ageing). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 77-78.

Question 986: Which of the following is NOT a clinical manifestation of Disseminated Intravascular Coagulation?

A. Microthrombi
B. Sheehan postpartum pituitary necrosis
C. Waterhouse-Friderichsen syndrome
D. Brain edema (Correct Answer)

Explanation: **Explanation:** **Disseminated Intravascular Coagulation (DIC)** is a thrombohemorrhagic disorder characterized by the excessive activation of coagulation, leading to widespread **microthrombi** in the microvasculature and the subsequent consumption of platelets and clotting factors (consumptive coagulopathy) [1], [2]. **Why Brain Edema is the Correct Answer:** Brain edema is typically a result of trauma, tumors, or metabolic disturbances leading to increased intracranial pressure. In the context of DIC, the primary CNS manifestations are **micro-infarcts** (due to thrombi) or **intracranial hemorrhage** (due to bleeding diathesis), rather than generalized cerebral edema [1]. **Analysis of Incorrect Options:** * **A. Microthrombi:** This is the hallmark of the "thrombotic phase" of DIC [1]. These fibrin thrombi lodge in small vessels of the kidneys, lungs, and brain, leading to ischemic organ damage [2]. * **B. Sheehan Postpartum Pituitary Necrosis:** This is a classic complication of DIC triggered by obstetric emergencies (e.g., abruptio placentae). The enlarged pituitary gland of pregnancy undergoes ischemic necrosis due to DIC-induced microthrombi [4]. * **C. Waterhouse-Friderichsen Syndrome:** This involves massive bilateral adrenal hemorrhage associated with *Neisseria meningitidis* sepsis. DIC is the underlying mechanism that causes the hemorrhagic infarction of the adrenal glands [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Peripheral Smear:** Look for **Schistocytes** (fragmented RBCs) indicating Microangiopathic Hemolytic Anemia (MAHA) [2]. * **Best Screening Test:** Platelet count (decreased) and PT/aPTT (prolonged) [3]. * **Most Specific Test:** Elevated **D-dimer** levels (indicates fibrinolysis). * **Common Triggers:** Sepsis (Gram-negative), Malignancy (APML - M3), and Obstetric complications [1], [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 672-673. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 625-626. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 151-152. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 150-151.

Question 987: Gain of function mutation in the RAS gene is equivalent to a loss of function mutation in which of the following?

A. Rb
B. Bcr-tyrosine kinase
C. Bcl-2
D. GAP protein (Correct Answer)

Explanation: ### Explanation **Concept Overview:** The **RAS protein** is a key molecular switch in cell signaling. It cycles between an **active state** (bound to GTP) and an **inactive state** (bound to GDP). * **Activation:** Stimulated by Guanine nucleotide exchange factors (GEFs). * **Inactivation:** Mediated by **GTPase-activating proteins (GAPs)**, which augment the intrinsic GTPase activity of RAS, hydrolyzing GTP to GDP and "turning off" the signal. **Why GAP Protein is Correct:** A **gain-of-function mutation** in the *RAS* gene (commonly at codons 12, 13, or 61) impairs the protein's ability to hydrolyze GTP. This keeps RAS permanently in the "ON" position, leading to continuous growth signaling. A **loss-of-function mutation** in **GAP proteins** (like Neurofibromin-1) results in the same outcome: the "brake" is removed, and RAS cannot be converted back to its inactive GDP-bound state. Therefore, both mutations lead to constitutive RAS activation. **Analysis of Incorrect Options:** * **A. Rb (Retinoblastoma protein):** A tumor suppressor that regulates the G1/S checkpoint [1]. While its loss leads to cancer, it functions downstream and independently of the direct RAS-GTP cycle [3]. * **B. Bcr-tyrosine kinase:** This is an oncogene (Philadelphia chromosome). A mutation here is a gain-of-function, not a loss-of-function [2]. * **C. Bcl-2:** An anti-apoptotic protein. Overexpression (gain-of-function) prevents cell death, but it does not mimic the biochemical mechanism of RAS activation. **Clinical Pearls for NEET-PG:** * **RAS** is the most common oncogene mutated in human tumors (approx. 30%). * **H-RAS** is associated with bladder tumors; **K-RAS** with colon, lung, and pancreatic tumors; **N-RAS** with melanomas and hematologic malignancies [2]. * **Neurofibromatosis Type 1 (NF1):** Caused by a mutation in the *NF1* gene, which encodes a GAP protein (Neurofibromin). This is a classic example of how losing a GAP mimics RAS activation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 292. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301.

Question 988: All of the following are types of selectin molecules except?

A. E-selectin
B. P-selectin
C. L-selectin
D. M-selectin (Correct Answer)

Explanation: **Explanation:** Selectins are a family of cell adhesion molecules (CAMs) that play a critical role in the initial phase of leukocyte recruitment: **Rolling** [1]. They are carbohydrate-binding lectins that bind to sialylated oligosaccharides (like Sialyl-Lewis X) on target cell surfaces. **Why M-selectin is the correct answer:** There is no molecule named **M-selectin**. The selectin family consists of only three members, categorized based on the cells where they were first identified [1]. Therefore, M-selectin is the "except" in this list. **Analysis of other options:** * **L-selectin (CD62L):** Expressed on **L**eukocytes (neutrophils, monocytes, T and B cells) [1]. It is crucial for the homing of lymphocytes to high endothelial venules in lymph nodes. * **E-selectin (CD62E):** Expressed on **E**ndothelial cells [1]. Its expression is induced by inflammatory cytokines like IL-1 and TNF. * **P-selectin (CD62P):** Found in **P**latelets and endothelial cells [1]. In endothelial cells, it is stored pre-formed in **Weibel-Palade bodies** and is rapidly redistributed to the cell surface upon stimulation by histamine or thrombin. **High-Yield NEET-PG Pearls:** 1. **Function:** Selectins mediate "Rolling," while Integrins (LFA-1, MAC-1) mediate "Firm Adhesion" [1]. 2. **Ligand:** The primary ligand for all three selectins is **Sialyl-Lewis X** (modified glycoprotein). 3. **Clinical Correlation:** A deficiency in Sialyl-Lewis X leads to **Leukocyte Adhesion Deficiency Type 2 (LAD II)**, characterized by recurrent bacterial infections and a lack of pus formation [2]. 4. **Storage:** Remember "P-selectin is in Weibel-Palade bodies" (P for P). These bodies also store Von Willebrand Factor (vWF). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 87. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 87-89.

Question 989: What are the principal actions of prostacyclin in inflammation?

A. Vasodilation (Correct Answer)
B. Vasoconstriction
C. Increased vascular permeability
D. Chemotaxis, leukocyte adhesion

Explanation: **Explanation:** Prostacyclin (**PGI2**) is a potent lipid mediator derived from arachidonic acid via the cyclooxygenase (COX) pathway [1]. It is primarily produced by vascular endothelial cells. **1. Why Option A is Correct:** The principal actions of Prostacyclin (PGI2) are **vasodilation** and the **inhibition of platelet aggregation** [1]. In the context of inflammation, PGI2 promotes increased blood flow to the site of injury (hyperemia), which contributes to the clinical signs of redness and heat. It acts as a physiological antagonist to Thromboxane A2 (TXA2). **2. Why Other Options are Incorrect:** * **B. Vasoconstriction:** This is the primary action of **Thromboxane A2 (TXA2)** and certain Leukotrienes (LTC4, LTD4, LTE4) [1]. * **C. Increased Vascular Permeability:** This is primarily mediated by **Histamine**, Bradykinin, and Leukotrienes (LTC4, LTD4, LTE4) [1]. While PGI2 can potentiate edema by increasing blood flow, it does not directly cause endothelial cell contraction. * **D. Chemotaxis and Leukocyte Adhesion:** These are mediated by **Leukotriene B4 (LTB4)**, Chemokines (IL-8), and Complement components (C5a) [1]. **NEET-PG High-Yield Pearls:** * **The "Balance" Concept:** PGI2 (Vasodilator/Anti-aggregant) and TXA2 (Vasoconstrictor/Pro-aggregant) maintain vascular homeostasis. An imbalance is linked to thrombosis and atherosclerosis. * **Aspirin's Role:** Low-dose aspirin irreversibly inhibits COX-1 in platelets (reducing TXA2), but endothelial cells can regenerate COX to produce PGI2, leading to a net antithrombotic effect. * **Prostaglandins and Pain:** PGE2 is the primary prostaglandin responsible for pain (sensitizing nerve endings) and fever. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 95-96.

Question 990: What is the most important cytokine responsible for the synthesis of acute phase proteins?

A. IL-1
B. IL-6 (Correct Answer)
C. IL-11
D. TNF alpha

Explanation: **Explanation:** **Correct Option: B (IL-6)** Interleukin-6 (IL-6) is the primary and most potent inducer of **acute-phase protein (APP)** synthesis by hepatocytes in the liver [1]. During inflammation, macrophages and other cells release cytokines that travel to the liver. IL-6 binds to its receptors on hepatocytes, activating the **JAK-STAT signaling pathway**, which leads to the transcription of genes for proteins like C-reactive protein (CRP), Fibrinogen, and Serum Amyloid A (SAA) [1]. While other cytokines contribute, IL-6 is considered the "chief" mediator of this systemic response. **Incorrect Options:** * **IL-1 & TNF-alpha:** These are "upstream" pro-inflammatory cytokines [1]. While they can stimulate the production of certain APPs and induce IL-6, their primary roles are in activating endothelium, inducing fever (via prostaglandin E2), and causing systemic manifestations like shock or cachexia [2]. * **IL-11:** This is a member of the IL-6 family and can stimulate APP synthesis, but its physiological contribution is significantly less than that of IL-6. It is clinically more relevant for its role in stimulating megakaryocytopoiesis (platelet production). **High-Yield Clinical Pearls for NEET-PG:** * **Positive APPs (Increase):** CRP (most sensitive), Fibrinogen (causes high ESR), Ferritin, Haptoglobin, and Complement proteins (C3, C4) [1]. * **Negative APPs (Decrease):** Albumin, Transferrin, and Transthyretin (Pre-albumin). * **ESR vs. CRP:** CRP rises and falls more rapidly than ESR, making it a better marker for acute changes. * **Hepcidin:** An acute-phase reactant induced by IL-6 that sequesters iron, leading to **Anemia of Chronic Disease**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 111. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 101.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free